Type 2 Diabetes Trial, Not Yet Recruiting NCT07685080 Sponsor: Escuela Universitaria de Osuna Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Not Yet Recruiting

NCT07685080
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with both type 2 diabetes and obesity.
  • People aged between 30 and 65 years.
  • People whose Body Mass Index (BMI) falls between 30 and 40 kg/m² (a measure of body weight relative to height).
  • People whose HbA1c (a blood test showing average blood sugar levels over roughly 3 months) is above 6.5%.
  • People whose fasting blood sugar level is at or above 126 mg/dL (7.0 mmol/L), measured after not eating.
  • People who are willing and able to give their formal agreement to take part in the study.
  • People who are available and willing to commit to a 20-week study period.
  • People who are able and willing to use a smartphone and receive text messages.
  • People who are able and willing to use a smartwatch and its accompanying mobile app.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have an obesity-related health condition that requires specialist referral, such as an eating disorder, a condition causing pressure in the brain (pseudotumor cerebri), sleep apnea, breathing problems during sleep, or joint/bone problems that limit physical activity.
  • People who have a psychiatric or medical condition that would make it difficult to follow the study's requirements.
  • People who have had a serious heart or blood vessel event — such as a heart attack, stroke, heart failure, or a procedure to unblock arteries — in the past 6 months.
  • People who have a medical condition that makes participation in a physical activity program inadvisable (confirm with trial site).
  • People who are currently using insulin to manage their diabetes.
  • People who have bone, joint, or other physical limitations that could make exercising safely difficult.
  • People who are currently receiving treatment for a cancerous tumour (other than a common, non-spreading type of skin cancer).
  • People who are currently being treated for, or have been diagnosed with, an eating disorder.
  • People who have planned weight-loss surgery — such as liposuction, a gastric band, or gastric bypass — within the next 5 months.
  • People who are currently pregnant, have given birth in the last 6 months, have been breastfeeding in the last 3 months, or are actively planning a pregnancy within the next 5 months.
  • People who are currently taking part in, or planning to join, a weight loss programme during the study period.
  • People who have lost more than 5 kilograms of body weight in the past 3 months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 10 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0034 650067474

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Escuela Universitaria de Osuna
Registry
ClinicalTrials.gov
Start date
1 October 2026
Est. completion
30 March 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Change from Baseline in Glycated Hemoglobin (HbA1c) at 20 Weeks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov